"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the SKIN.
| Descriptor ID |
D012878
|
| MeSH Number(s) |
C04.588.805 C17.800.882
|
| Concept/Terms |
Skin Neoplasms- Skin Neoplasms
- Neoplasms, Skin
- Neoplasm, Skin
- Skin Neoplasm
Cancer of Skin- Cancer of Skin
- Skin Cancers
- Cancer of the Skin
- Skin Cancer
- Cancer, Skin
- Cancers, Skin
|
Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".
This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 0 | 6 |
| 1995 | 4 | 1 | 5 |
| 1996 | 6 | 1 | 7 |
| 1997 | 3 | 1 | 4 |
| 1998 | 6 | 1 | 7 |
| 1999 | 6 | 0 | 6 |
| 2000 | 4 | 0 | 4 |
| 2001 | 5 | 0 | 5 |
| 2002 | 2 | 1 | 3 |
| 2003 | 8 | 0 | 8 |
| 2004 | 13 | 1 | 14 |
| 2005 | 9 | 3 | 12 |
| 2006 | 7 | 0 | 7 |
| 2007 | 8 | 1 | 9 |
| 2008 | 8 | 2 | 10 |
| 2009 | 4 | 0 | 4 |
| 2010 | 8 | 1 | 9 |
| 2011 | 6 | 2 | 8 |
| 2012 | 9 | 2 | 11 |
| 2013 | 22 | 3 | 25 |
| 2014 | 8 | 0 | 8 |
| 2015 | 7 | 1 | 8 |
| 2016 | 18 | 2 | 20 |
| 2017 | 9 | 1 | 10 |
| 2018 | 11 | 0 | 11 |
| 2019 | 16 | 0 | 16 |
| 2020 | 14 | 2 | 16 |
| 2021 | 10 | 1 | 11 |
| 2022 | 11 | 0 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.
-
Oral Propranolol Used as Adjunct Therapy in Cutaneous Angiosarcoma. Cutis. 2022 12; 110(6):E33-E36.
-
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 09 01; 158(9):1031-1039.
-
Melanoma risk during immunomodulating treatment. Melanoma Res. 2022 12 01; 32(6):411-418.
-
Histologic Screening of Malignant Melanoma, Spitz, Dermal and Junctional Melanocytic Nevi Using a Deep Learning Model. Am J Dermatopathol. 2022 Sep 01; 44(9):650-657.
-
Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Leuk Lymphoma. 2022 11; 63(11):2757-2759.
-
Response to "Comment on 'Guidelines of care for the management of actinic keratosis'". J Am Acad Dermatol. 2023 02; 88(2):473.
-
Letter from the Editor: Delays in melanoma diagnosis. J Am Acad Dermatol. 2022 09; 87(3):535.
-
Association of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors. J Geriatr Oncol. 2022 09; 13(7):1003-1010.
-
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma. J Immunother Cancer. 2022 05; 10(5).
-
Skin Cancer Education in the Medical School Curriculum. Cutis. 2022 05; 109(5):257-258.